NCT05872295
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05872295
Title IKS014 in Advanced Solid Tumors That Express HER2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Iksuda Therapeutics Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NZL | AUS

Facility Status City State Zip Country Details
Hoag Memorial Hospital Presbyterian NOT_YET_RECRUITING Newport Beach California 92663 United States Details
Dana Farber Cancer Institute NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Tennessee Oncology NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
Concord Repatriation General Hospital Medical Oncology Clinical Trials Unit RECRUITING Concord New South Wales 2139 Australia Details
Macquarie University RECRUITING Sydney New South Wales 2109 Australia Details
Westmead Hospital RECRUITING Westmead New South Wales 2145 Australia Details
Peninsula & South Eastern Haematology and Oncology Group (PSEHOG) RECRUITING Frankston Victoria 3199 Australia Details
Alfred Health RECRUITING Melbourne Victoria 3004 Australia Details
Linear Clinical Research RECRUITING Nedlands Western Australia 6009 Australia Details
Auckland City Hospital NOT_YET_RECRUITING Auckland New Zealand Details
National Cancer Centre Singapore NOT_YET_RECRUITING Singapore Singapore Details
Tan Tock Seng Hospital NOT_YET_RECRUITING Singapore Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field